AX-2911

N/A

Report date: 2025/05/19 11:07:17
NME

Base Information

Drug NameAX-2911
Drug Alias NameAX-2911
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of Action1-acylglycerol-3-phosphate O-acyltransferase PNPLA3 modulators
Targets1-acylglycerol-3-phosphate O-acyltransferase PNPLA3
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProqr Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesProqr Therapeutics
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A